Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of Morning Symptoms in Clinical Control of COPD

NCT01266395 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT01266395
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01266395 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of Morning Symptoms in Clinical Control of COPD
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Completed
Start date
January 31, 2010
Completion date
July 31, 2011
Enrollment
1,268 (actual)
Sites
52

Conditions

As the registry lists them; a condition with its own page is linked.

copd